164 related articles for article (PubMed ID: 38643486)
1. Racial disparities in disease-specific mortality and surgical management of patients with ductal carcinoma in situ with microinvasion.
Chen JC; Handley D; Elsaid MI; Fisher JL; Owusu-Brackett N; Azap L; Bhattacharyya O; Pawlik TM; Carson WE; Obeng-Gyasi S
J Surg Oncol; 2024 Jun; 129(7):1179-1186. PubMed ID: 38643486
[TBL] [Abstract][Full Text] [Related]
2. Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.
Eaglehouse YL; Georg MW; Shriver CD; Zhu K
JAMA Surg; 2019 Mar; 154(3):e185113. PubMed ID: 30673075
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health.
Hung MC; Ekwueme DU; Rim SH; White A
Cancer Epidemiol; 2016 Dec; 45():112-118. PubMed ID: 27792934
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.
Berkman A; F Cole B; Ades PA; Dickey S; Higgins ST; Trentham-Dietz A; Sprague BL; Lakoski SG
Breast Cancer Res Treat; 2014 Nov; 148(2):407-13. PubMed ID: 25326349
[TBL] [Abstract][Full Text] [Related]
7. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2018 Feb; 167(3):787-795. PubMed ID: 29119353
[TBL] [Abstract][Full Text] [Related]
8. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
Fang Y; Wu J; Wang W; Fei X; Zong Y; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
Oncotarget; 2016 Sep; 7(39):64182-64190. PubMed ID: 27577080
[TBL] [Abstract][Full Text] [Related]
9. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
Liu Y; West R; Weber JD; Colditz GA
Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
[TBL] [Abstract][Full Text] [Related]
10. Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical Trial.
Kantor O; King TA; Jones A; Glass C; Leonard SJ; Ogayo ER; Mayer EL; Chavez-MacGregor M; Newman LA; Freedman RA; Mittendorf EA
Ann Surg Oncol; 2023 Dec; 30(13):8404-8411. PubMed ID: 37777685
[TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Disparities in Lung Adenocarcinoma Survival: A Competing-Risk Model.
Wu X; Wang Y; Lin X; Wang Z; Xu J; Lv W; Hu J
Clin Lung Cancer; 2020 May; 21(3):e171-e181. PubMed ID: 31787547
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.
Magnoni F; Massari G; Santomauro G; Bagnardi V; Pagan E; Peruzzotti G; Galimberti V; Veronesi P; Sacchini VS
Br J Surg; 2019 Mar; 106(4):375-383. PubMed ID: 30791092
[TBL] [Abstract][Full Text] [Related]
13. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in risk of second breast tumors after ductal carcinoma in situ.
Liu Y; Colditz GA; Gehlert S; Goodman M
Breast Cancer Res Treat; 2014 Nov; 148(1):163-73. PubMed ID: 25261293
[TBL] [Abstract][Full Text] [Related]
15. Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer.
Kruper L; Xu X; Henderson K; Bernstein L
Ann Surg Oncol; 2011 Oct; 18(11):3210-9. PubMed ID: 21863363
[TBL] [Abstract][Full Text] [Related]
16. Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Hillyer GC; Chen L; Hershman DL
Breast Cancer Res Treat; 2016 Jul; 158(2):373-84. PubMed ID: 27365080
[TBL] [Abstract][Full Text] [Related]
17. Updated racial disparities in incidence, clinicopathological features and prognosis of hypopharyngeal squamous carcinoma in the United States.
Liang Z; Wu M; Wang P; Quan H; Zhao J
PLoS One; 2023; 18(3):e0282603. PubMed ID: 36928727
[TBL] [Abstract][Full Text] [Related]
18. Racial/ethnic disparities in early-onset colorectal cancer: implications for a racial/ethnic-specific screening strategy.
Acuna-Villaorduna AR; Lin J; Kim M; Goel S
Cancer Med; 2021 Mar; 10(6):2080-2087. PubMed ID: 33641251
[TBL] [Abstract][Full Text] [Related]
19. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
Sagara Y; Mallory MA; Wong S; Aydogan F; DeSantis S; Barry WT; Golshan M
JAMA Surg; 2015 Aug; 150(8):739-45. PubMed ID: 26039049
[TBL] [Abstract][Full Text] [Related]
20. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
